These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 14274828)

  • 21. Update on emerging urate-lowering therapies.
    Chohan S; Becker MA
    Curr Opin Rheumatol; 2009 Mar; 21(2):143-9. PubMed ID: 19339925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gout and uric acid nephropathy: some new aspects in diagnosis and treatment.
    Löffler W; Simmonds HA; Gröbner W
    Klin Wochenschr; 1983 Dec; 61(24):1233-9. PubMed ID: 6689351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug treatment of gout.
    Kelley WN; Wyngaarden JB
    Semin Drug Treat; 1971 Sep; 1(2):119-47. PubMed ID: 4949305
    [No Abstract]   [Full Text] [Related]  

  • 24. ALLOPURNOL IN THE TREATMENT OF GOUT.
    WYNGAARDEN JB; RUNDLES RW; METZ EN
    Ann Intern Med; 1965 Apr; 62():842-7. PubMed ID: 14274848
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of allopurinol on the metabolism of uric acid].
    Swiderska-Kulikowa B; Jelińska S
    Pol Arch Med Wewn; 1973 Apr; 50(4):391-8. PubMed ID: 4574007
    [No Abstract]   [Full Text] [Related]  

  • 26. Febuxostat: a selective xanthine-oxidase/xanthine-dehydrogenase inhibitor for the management of hyperuricemia in adults with gout.
    Ernst ME; Fravel MA
    Clin Ther; 2009 Nov; 31(11):2503-18. PubMed ID: 20109996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [TREATMENT OF GOUT WITH URACIL-6-CARBOXYLIC ACID AND ITS DERIVATIVES].
    DELBARRE F; AUSCHER C
    Presse Med (1893); 1963 Sep; 71():1765-8. PubMed ID: 14091585
    [No Abstract]   [Full Text] [Related]  

  • 28. Allopurinol, purines, and pyrimidines.
    Lancet; 1971 Jan; 1(7689):73. PubMed ID: 4099227
    [No Abstract]   [Full Text] [Related]  

  • 29. [Observations on a random group of gout patients].
    Einaudi G; Marrazzi G; Pecchiura G
    Reumatismo; 1972; 24(1):21-9. PubMed ID: 4671625
    [No Abstract]   [Full Text] [Related]  

  • 30. The treatment of gout and disorders of uric acid metabolism with allopurinol.
    Ogryzlo MA; Urowitz MB; Weber HM; Houpt JB
    Can Med Assoc J; 1966 Nov; 95(22):1120-7. PubMed ID: 5923471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of gout.
    Goldfinger SE
    N Engl J Med; 1971 Dec; 285(23):1303-6. PubMed ID: 4941493
    [No Abstract]   [Full Text] [Related]  

  • 32. Allopurinol in primary gout with and after the administration of uricosuric agents.
    Kersley GD
    Ann Rheum Dis; 1966 Nov; 25(6 Suppl):643-4. PubMed ID: 5958694
    [No Abstract]   [Full Text] [Related]  

  • 33. [Uricosuric agent].
    Ohno I
    Nihon Rinsho; 2008 Apr; 66(4):743-7. PubMed ID: 18409525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Uric acid and its metabolism].
    Kissel P; Royer R
    Presse Med (1893); 1968 Dec; 76(49):2317-8. PubMed ID: 5737248
    [No Abstract]   [Full Text] [Related]  

  • 35. Purine metabolism and inhibition of xanthine oxidase in severely hypoxic neonates going onto extracorporeal membrane oxygenation.
    Marro PJ; Baumgart S; Delivoria-Papadopoulos M; Zirin S; Corcoran L; McGaurn SP; Davis LE; Clancy RR
    Pediatr Res; 1997 Apr; 41(4 Pt 1):513-20. PubMed ID: 9098853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. THE TREATMENT OF GOUT.
    TREADWELL B
    N Z Med J; 1964 Sep; 63():567-74. PubMed ID: 14210072
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of gout with allopurinol. A study of 106 cases.
    Delbarre F; Amor B; Auscher C; de Gery A
    Ann Rheum Dis; 1966 Nov; 25(6 Suppl):627-33. PubMed ID: 5335060
    [No Abstract]   [Full Text] [Related]  

  • 38. Impact of anti-inflammatory therapies, xanthine oxidase inhibitors and other urate-lowering therapies on cardiovascular diseases in gout.
    Richette P; Frazier A; Bardin T
    Curr Opin Rheumatol; 2015 Mar; 27(2):170-4. PubMed ID: 25594854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physiologic and biochemical basis for the treatment of gout and hyperuricemia.
    Mikkelsen WM; Robinson WD
    Med Clin North Am; 1969 Nov; 53(6):1331-47. PubMed ID: 4900718
    [No Abstract]   [Full Text] [Related]  

  • 40. Anti-nociceptive properties of the xanthine oxidase inhibitor allopurinol in mice: role of A1 adenosine receptors.
    Schmidt AP; Böhmer AE; Antunes C; Schallenberger C; Porciúncula LO; Elisabetsky E; Lara DR; Souza DO
    Br J Pharmacol; 2009 Jan; 156(1):163-72. PubMed ID: 19133997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.